JMP Securities Starts Incyte (INCY) at Market Outperform

May 13, 2008 10:16 AM EDT

JMP Securities initiates coverage on Incyte (Nasdaq: INCY) with a Market Outperform rating.

Incyte Corporation operates as a drug discovery and development company, which focuses on developing proprietary small molecule drugs to treat human immunodeficiency virus (HIV), diabetes, oncology, and inflammation diseases. [BCS]


Related Categories

New Coverage

Stocks Mentioned

INCY 3.37

-0.02 -0.59%
Volume: 1,015,194
Track INCY


Add Your Comment